Boston Scientific…
USUSDBoston Scientific Corp (VI:BSXC) — Medical Devices. Numero di borse in cui sono quotate le azioni della società: 5. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.
Informazioni sull'Azienda
- Sito Web
- bostonscientific.com
- Relazioni con gli Investitori
- bostonscientific.com/en-US/investor-relations-redirect.html
- Settore
- Healthcare · Medical Devices
- Sede Centrale
- MARLBOROUGH, United States
- Gestione
- Ultimi Report
- Dipendenti
- 59 000
- Fondata
- 1979
- IPO
- 1992-05-19
- Quotata dal
- 27.06.2019 (VI:BSXC)
- Azioni in Circolazione
- 1.45 Mld al 2026-07-30
- Flottante
- 1.44 Mld
- Capitalizzazione di Mercato
- 66.06 Mld USD
- Insider
- 0.25%
- Investitori Istituzionali
- 94.73%
- Settore (SIC)
- Surgical & Medical Instruments & Apparatus
- Forma Giuridica
- XTIQ
- ISIN
- US1011371077
- LEI
- Y6ZDD9FP4P8JSSJMW954
- P/E
- 18.7
- P/B
- 2.48
- FCF
- 3.63 Mld USD
- Debito
- 10.9 Mld USD2.9 anni di FCF
- Utili e FCF — per i 12 mesi a 30.06.2026 (l'ultimo rapporto dell'azienda).
- Utile Netto
- NAV
Descrizione
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Borse e Ticker
| Borsa | Ticker | Valuta | Prezzo | Tipo |
|---|---|---|---|---|
| azioni ordinarie | ||||
| US USA Stocks | BSX principale | USD | 42.69 +0.61% | azioni ordinarie |
| LSE London Stock Exchange | 0HOY IOB | GBP | — | azioni ordinarie |
| MI Borsa Italiana (Milan) | 1BSX secondaria | EUR | 38.565 +2.88% | azioni ordinarie |
| VI Vienna Stock Exchange | BSXC secondaria | EUR | 39.785 +1.20% | azioni ordinarie |
| XETRA Xetra | BSX secondaria | EUR | 39.825 +1.32% | azioni ordinarie |
| certificato di deposito | ||||
| SA B3 Sao Paulo | B1SX34 | BRL | 53.28 -3.58% | certificato di deposito |
Notizie di Questa Settimana
Comunicati stampa dal sito web per investitori della società, aggiornati quotidianamente. I link conducono al sito web dell'azienda. I titoli sono nella lingua originale, come sul sito web dell'azienda.
| 28.10.2026 | Learn about our Q3 2026 earnings |
Principali Azionisti
| Detentore | Quota | Azioni | Data del Rapporto |
|---|---|---|---|
| Blackrock Inc. | 8.95% | 129.68 Mln | 2026-06-30 |
| Vanguard Capital Managem… | 6.7% | 97.09 Mln | 2026-06-30 |
| State Street Corporation | 4.84% | 70.11 Mln | 2026-06-30 |
| Primecap Management Comp… | 3.49% | 50.52 Mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.26% | 47.18 Mln | 2026-06-30 |
| FMR, LLC | 3.15% | 45.7 Mln | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.66% | 38.52 Mln | 2026-06-30 |
| Geode Capital Management… | 2.31% | 33.44 Mln | 2026-06-30 |
| VANGUARD CHESTER FUNDS-V… | 2.13% | 30.83 Mln | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.06% | 29.79 Mln | 2026-06-30 |
| Shaw D.E. & Co., Inc. | 1.76% | 25.46 Mln | 2026-06-30 |
| Massachusetts Financial… | 1.72% | 24.86 Mln | 2026-06-30 |
| JPMORGAN CHASE & CO | 1.65% | 23.91 Mln | 2026-06-30 |
| iShares Trust-iShares Co… | 1.38% | 20.05 Mln | 2026-07-31 |
| Fidelity Concord Street… | 1.33% | 19.22 Mln | 2026-07-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.26% | 18.21 Mln | 2026-08-31 |
| VANGUARD SPECIALIZED FUN… | 1.04% | 15.07 Mln | 2026-04-30 |
| Growth Fund of America | 0.78% | 11.25 Mln | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.74% | 10.68 Mln | 2026-08-31 |
| Fidelity Rutland Square… | 0.66% | 9.61 Mln | 2026-07-31 |
| MAHONEY MICHAEL F (Chief… | ≈0.11% | 1.61 Mln | 2026-08-03 |
| BRENNAN DANIEL J (Chief… | ≈0.02% | 225 808 | 2025-02-19 |
| FITZGERALD JOSEPH MICHAE… | ≈0.02% | 219 141 | 2026-02-13 |
| BUTCHER ARTHUR C (Office… | ≈0.01% | 77 115 | 2026-05-01 |
| SUNUNU JOHN E (Director) | ≈0% | 54 723 | 2025-05-08 |
| BROWN VANCE R (General C… | ≈0% | 54 244 | 2026-02-13 |
| WICHMANN DAVID S (Direct… | ≈0% | 45 382 | 2026-05-07 |
| MONSON JONATHAN R (Chief… | ≈0% | 39 063 | 2026-07-01 |
| LUDWIG EDWARD J. (Direct… | ≈0% | 30 359 | 2026-07-31 |
| CARRUTHERS WENDY (Office… | ≈0% | 29 308 | 2024-12-02 |
Accedi con Google